LCAR-G08 / Legend Biotech - LARVOL DELTA

A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC) (clinicaltrials.gov) - P1 | N=17 | Terminated | Sponsor: Peking University | N=42 ➔ 17 | Trial completion date: Mar 2028 ➔ Oct 2025 | Recruiting ➔ Terminated; achieved the proof of concept

Enrollment change • Trial completion date • Trial termination • Esophageal Cancer • Gastric Cancer • Gastrointestinal Cancer • Solid Tumor

A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC) (clinicaltrials.gov) - P1 | N=42 | Recruiting | Sponsor: Peking University

Metastases • New P1 trial • Gastrointestinal Cancer • Gastrointestinal Disorder • Oncology • Solid Tumor